NCT02950259 2025-12-03
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Providence Health & Services
Phase 1 Completed
Providence Health & Services
NantBioScience, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Virginia